Zobrazeno 1 - 9
of 9
pro vyhledávání: '"B. Vittrup Jensen"'
Autor:
Dorte Nielsen, Estrid Høgdall, P. Grundtvig Sørensen, P. G. Nielsen, A. Fullerton, Iben Kümler, S. Theile, B. Vittrup Jensen, W. Skovrider-Ruminski, J. Palshof
Publikováno v:
Cancer Chemotherapy and Pharmacology
Kümler, I, Sørensen, P G, Palshof, J, Høgdall, E, Skovrider-Ruminski, W, Theile, S, Fullerton, A, Nielsen, P G, Jensen, B V & Nielsen, D L 2019, ' Oral administration of irinotecan in patients with solid tumors : an open-label, phase I, dose escalating study evaluating safety, tolerability and pharmacokinetics ', Cancer Chemotherapy and Pharmacology, vol. 83, no. 1, pp. 169-178 . https://doi.org/10.1007/s00280-018-3720-7
Kümler, I, Sørensen, P G, Palshof, J, Høgdall, E, Skovrider-Ruminski, W, Theile, S, Fullerton, A, Nielsen, P G, Jensen, B V & Nielsen, D L 2019, ' Oral administration of irinotecan in patients with solid tumors : an open-label, phase I, dose escalating study evaluating safety, tolerability and pharmacokinetics ', Cancer Chemotherapy and Pharmacology, vol. 83, no. 1, pp. 169-178 . https://doi.org/10.1007/s00280-018-3720-7
Background: Oral drug formulations have several advantages compared to intravenous formulation. Apart from patient convenience and favorable pharmacoeconomics, they offer the possibility of frequent drug administration at home. In this study, we pres
Autor:
Tark Kim, Mohammed Z.H. Farooqui, K K Shiu, Patricia Marinello, C. de la Fouchardiere, T. Andre, J. Alcaide-Garcia, W.P. Yong, Ping Yang, Luis A. Diaz, Dung T. Le, B. Vittrup Jensen, Rocio Garcia-Carbonero, L. Henrik Jensen, Johanna C. Bendell, D. Smith, Elena Elez, Peter Gibbs, Takayuki Yoshino, Fernando Rivera
Publikováno v:
Annals of Oncology. 31:S1284-S1285
Autor:
S.E. Nielsen, Ursula Falkmer, Mette Karen Yilmaz, Julia S. Johansen, Stig E. Bojesen, Louise Skau Rasmussen, Jane Preuss Hasselby, Inna Chen, Per Pfeiffer, B. Vittrup Jensen, Martin Bøgsted, Carsten Palnæs Hansen, N.H. Holländer, Jon Kroll Bjerregaard, Laurids Østergaard Poulsen, Fahimeh Andersen, Astrid Z. Johansen
Publikováno v:
Rasmussen, L S, Yilmaz, M, Falkmer, U G, Poulsen, L O, Bojesen, S E, Jensen, B V, Johansen, A Z, Chen, I M, Hansen, C P, Hasselby, J P, Pfeiffer, P, Bjerregaard, J K, Nielsen, S E, Andersen, F Z, Hollander, N H, Bogsted, M & Johansen, J S 2019, ' Pre-treatment serum 25-hydroxyvitamin D levels and survival in a Danish cohort of patients with pancreatic cancer ', Annals of Oncology, vol. 30, no. Suppl. 5, 699P, pp. v266-v267 . https://doi.org/10.1093/annonc/mdz247.026
Rasmussen, L S, Yilmaz, M, Falkmer, U G, Poulsen, L O, Bojesen, S E, Jensen, B V, Johansen, A Z, Chen, I M, Hansen, C P, Hasselby, J P, Pfeiffer, P, Bjerregaard, J K, Nielsen, S E, Andersen, F Z, Hollander, N H, Bogsted, M & Johansen, J S 2019, ' Pre-treatment serum 25-hydroxyvitamin D levels and survival in a Danish cohort of patients with pancreatic cancer ', Annals of Oncology, vol. 30, no. Suppl. 5, 699P . https://doi.org/10.1093/annonc/mdz247.026
Rasmussen, L S, Yilmaz, M, Falkmer, U G, Poulsen, L O, Bojesen, S E, Jensen, B V, Johansen, A Z, Chen, I M, Hansen, C P, Hasselby, J P, Pfeiffer, P, Bjerregaard, J K, Nielsen, S E, Andersen, F Z, Hollander, N H, Bogsted, M & Johansen, J S 2019, ' Pre-treatment serum 25-hydroxyvitamin D levels and survival in a Danish cohort of patients with pancreatic cancer ', Annals of Oncology, vol. 30, no. Suppl. 5, 699P . https://doi.org/10.1093/annonc/mdz247.026
Background 25-hydroxyvitamin D and active analogues have shown to inhibit growth of pancreatic cancer (PC) cell lines. However, studies describing the relationship between serum levels of vitamin D and survival in PC patients have shown conflicting r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9403c9e08d19e5f4f40dd7045a13dc3
https://portal.findresearcher.sdu.dk/da/publications/0325920f-747a-4be3-a552-efe47b4e166b
https://portal.findresearcher.sdu.dk/da/publications/0325920f-747a-4be3-a552-efe47b4e166b
Autor:
Dorte Nielsen, C. Qvortrup, Zsofia Sztupinszki, Halfdan Sorbye, B. Vittrup Jensen, J. V. Schou, Per Pfeiffer, Bengt Glimelius, Julia S. Johansen
Publikováno v:
Schou, J V, Sztupinszki, Z, Johansen, J S, Nielsen, D L, Glimelius, B, Qvortrup, C, Sorbye, H, Jensen, B V & Pfeiffer, P 2019, ' High circulating miR-1247 is a marker for poor prognosis in patients with metastatic colorectal cancer treated with chemotherapy and cetuximab ', Annals of Oncology, vol. 30, no. Suppl. 5, 624P, pp. v236 . https://doi.org/10.1093/annonc/mdz246.101
Background MicroRNAs (miRs) are small non-coding RNAs. Circulating miRs in plasma are deregulated in patients with metastatic colorectal cancer (mCRC). The aim was to find prognostic circulating miRs for overall survival (OS) in patients with mCRC tr
Publikováno v:
Annals of Oncology. 7:687-693
Summary Background Paclitaxel has shown activity in metastatic breast cancer, including anthracycline-resistant breast cancer. The efficacy, toxicity and optimal scheduling of the combination of the two drugs needs to be defined. Patients and methods
Publikováno v:
European Journal of Cancer. 51:S132
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.